Elevance Health, Inc. (ELV) — Analysis Summary
Elevance Health, Inc. (ELV) has a market cap of $86.55B with year-over-year revenue growth of +14.2%. Net margin stands at 3.4%. The stock trades at a P/E ratio of 17.4.
Key Takeaways
- Revenue changed +14.2% year-over-year
- Net margin of 3.4%
- P/E ratio of 17.4
Compared to other companies in the HOSPITAL & MEDICAL SERVICE PLANS sector, ELV posted revenue growth of +14.2% and trades at a P/E of 17.4.
Elevance Health, Inc. (ELV)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsWatch List
Some caution signals are active and should be weighed alongside the valuation work.
Debt/EBITDA at 4.4x — elevated leverage
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
Sector
HOSPITAL & MEDICAL SERVICE PLANS
Employees
97,100
Headquarters
INDIANAPOLIS, IN
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Annual Dividend/Share
$6.88
Dividend Yield
1.74%
Dividend History
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.